Abstract
Deep-learning techniques have significantly advanced small-molecule drug discovery. However, a critical gap remains between representation learning and small molecule generations, limiting their effectiveness in developing new drugs. We introduce Ouroboros, a unified framework that integrates molecular representation learning with generative modeling, enabling efficient chemical space exploration using pre-trained molecular encodings. By reframing molecular generation as a process of encoding space compression and decompression, Ouroboros resolves the challenges associated with iterative molecular optimization and facilitates directed chemical evolution within the encoding space. Comprehensive experimental tests demonstrate that Ouroboros significantly outperforms conventional approaches across multiple drug discovery tasks, including ligand-based virtual screening, chemical property prediction, and multi-target inhibitor design and optimization. Unlike task-specific models in traditional approaches, Ouroboros leverages a unified framework to achieve superior performance across diverse applications. Ouroboros offers a novel and highly scalable protocol for rapid chemical space exploration, fostering a potential paradigm shift in AI-driven drug discovery.
Full text
1,782 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Deep-learning techniques have significantly advanced small-molecule drug discovery. However, a critical gap remains between representation learning and small molecule generations, limiting their effectiveness in developing new drugs. We introduce Ouroboros, a unified framework that integrates molecular representation learning with generative modeling, enabling efficient chemical space exploration using pre-trained molecular encodings. By reframing molecular generation as a process of encoding space compression and decompression, Ouroboros resolves the challenges associated with iterative molecular optimization and facilitates directed chemical evolution within the encoding space. Comprehensive experimental tests demonstrate that Ouroboros significantly outperforms conventional approaches across multiple drug discovery tasks, including ligand-based virtual screening, chemical property prediction, and multi-target inhibitor design and optimization. Unlike task-specific models in traditional approaches, Ouroboros leverages a unified framework to achieve superior performance across diverse applications. Ouroboros offers a novel and highly scalable protocol for rapid chemical space exploration, fostering a potential paradigm shift in AI-driven drug discovery.
Competing Interest Statement
H.L., M.L., C.C., C.L. and J.Z are affiliated with DeepMed Technology (Suzhou) Co., Ltd, but this affiliation did not influence the study design, data analysis, or interpretation of results. The authors declare no other competing interests.
Data availability
All molecular and benchmark datasets used in this study are collected from public resources and can be downloaded from https://zhanglab.comp.nus.edu.sg/Ouroboros/ and https://github.com/Wang-Lin-boop/Ouroboros.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.